Sato, H., Okonogi, N., & Nakano, T. (2020). Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment. Int J Clin Oncol.
Citação norma ChicagoSato, Hiro, Noriyuki Okonogi, and Takashi Nakano. "Rationale of Combination of Anti-PD-1/PD-L1 Antibody Therapy and Radiotherapy for Cancer Treatment." Int J Clin Oncol 2020.
ציטוט MLASato, Hiro, Noriyuki Okonogi, and Takashi Nakano. "Rationale of Combination of Anti-PD-1/PD-L1 Antibody Therapy and Radiotherapy for Cancer Treatment." Int J Clin Oncol 2020.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.